Steadiwear

Steadiwear operates at the intersection of medical devices, assistive technology, and wearables, with a focused product aimed at action tremor associated with Essential Tremor and Parkinson’s Disease. Its primary differentiation is a passive, battery-free stabilization approach rather than an electronically powered wearable. The Steadi-3 Plus uses magnetic tuned-mass damping and a counterbalancing flywheel to reduce involuntary wrist movement without charging, medication, or surgery. The company also states that its device is registered as a Class I medical device with both the FDA and Health Canada, which supports a regulated-device positioning rather than a general consumer wellness product. Its Toronto base, nine reported investors, and participation in the Mobility Unlimited Hub give it connections across aging, brain health, and mobility ecosystems. The company remains small, with an employee range of one to ten, and its commercial position is still developing. The September 2025 CAD 2 million venture round and distribution-expansion plans indicate a shift from product development toward broader market adoption, but public evidence of sales scale, reimbursement, or market share is limited.

Steadiwear’s trajectory shows a long product-development period followed by a recent push toward commercialization. Founded in 2015, the company raised CAD 1.1 million in seed funding on Jul 26, 2021, with 3W Partners as lead investor and additional participation from the Ontario Brain Institute and the Center of Aging and Brain Health Innovation. The next clear inflection point came on Sep 24, 2025, when Steadiwear recorded a CAD 2 million venture round, approximately USD 1.44 million, plus separate grant and debt-financing activity. This brought total recorded funding to approximately USD 2.32 million and expanded the investor group to nine organizations. The company also entered the Mobility Unlimited Hub’s second cohort on Aug 6, 2025, adding a mobility-sector development channel before the September financing. Product activity has centered on the Steadi-3 and Steadi-3 Plus, a battery-free glove using passive magnetic damping. The September 2025 financing was described as supporting commercial rollout and distribution expansion, suggesting that the current growth priority is moving beyond validation and into sales execution. The company remains lean, with one to ten employees and two identified current positions, so execution capacity and channel development are important constraints to monitor.